Il Dong elected Chung Yeon-jin as a board of director.

Published: 2005-05-31 06:56:00

Updated: 2005-05-31 06:56:00

Il Dong reported the 62th fiscal year business performance at 197.3 billion won of sales and 16.5 billion won of ordinary income in the general shareholders meeting at the head office auditorium on May 27.

The dividend was allocated 700 won per share in cash and the 62th financial statements i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK